mTOR Expression in Liver Transplant Candidates with Hepatocellular Carcinoma: Impact on Histological Features and Tumour Recurrence

(1) Background: The mammalian target of rapamycin (mTOR) pathway activation is critical for hepatocellular carcinoma (HCC) progression. We aimed to evaluate the mTOR tissue expression in liver transplant (LT) patients and to analyse its influence on post-LT outcomes. (2) Methods: Prospective study i...

Descripción completa

Detalles Bibliográficos
Autores principales: Guerrero, Marta, Ferrín, Gustavo, Rodríguez-Perálvarez, Manuel, González-Rubio, Sandra, Sánchez-Frías, Marina, Amado, Víctor, Pozo, Juan C., Poyato, Antonio, Ciria, Rubén, Ayllón, María D., Barrera, Pilar, Montero, José L., de la Mata, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359509/
https://www.ncbi.nlm.nih.gov/pubmed/30650598
http://dx.doi.org/10.3390/ijms20020336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359509/
https://www.ncbi.nlm.nih.gov/pubmed/30650598
http://dx.doi.org/10.3390/ijms20020336

Ejemplares similares